NCT06906341 2026-04-14Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological CancersCorcept TherapeuticsPhase 2 Recruiting270 enrolled
NCT03562897 2022-07-06Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial CancerCatalysis SLPhase 2 Completed40 enrolled
NCT01379534 2015-05-20A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial CancerNovartisPhase 2 Completed53 enrolled 10 charts
NCT00190983 2009-11-20A Trial for Patients With Advanced/Recurrent Cervical CancerEli Lilly and CompanyPhase 2 Completed29 enrolled 14 charts
NCT00377520 2009-11-20A Trial for Patients With Advanced/Recurrent Endometrial CancerEli Lilly and CompanyPhase 2 Completed27 enrolled 10 charts
NCT00121030 2007-12-24Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to ChemotherapyAmgenPhase 2 Completed